Who
Sean Godbout
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Biogen.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2025
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —27 at $0.00 | filing |
| 2 Oct 2026filed 5 Oct 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code F | $1,7598 at $219.88 | filing |
| 2 Oct 2026filed 5 Oct 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —27 at $0.00 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code A | —985 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —181 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code F | $9,92454 at $183.78 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —181 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —181 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —181 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code F | $9,92454 at $183.78 | filing |
| 13 Feb 2026filed 17 Feb 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —257 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code F | $15K76 at $201.18 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —305 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —257 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —305 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB Biogenoption or derivative · Biotechnology | SEC FORM 4 Code M | —517 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code F | $21K103 at $201.18 | filing |
| 6 Feb 2026filed 10 Feb 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code M | —517 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.